Therapeutic Asset Ratings

278 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Rilvegostomig Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Rilvegostomig Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Sarilumab Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Sarilumab Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Sarilumab Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Talzenna Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Talzenna Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
TESTOSTERONE UNDECYLATE Ductal Breast Carcinoma In Situ	QuantumLeap Healthcare Collaborative	P2	CCC (53)
TRASTUZUMAB Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trastuzumab Deruxtecan Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trastuzumab Deruxtecan Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trastuzumab Deruxtecan Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trastuzumab Duocarmazine Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trastuzumab Duocarmazine Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trastuzumab Duocarmazine Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trastuzumab Emtansine Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trastuzumab Emtansine Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trastuzumab Emtansine Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trebananib Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trebananib Breast Cancer	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trebananib Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trebananib Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trilaciclib Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trilaciclib Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Trilaciclib Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)

Showing 76 to 100 of 278 assets

PreviousPage 4 of 12Next